Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in relapsing-Remitting Multiple Sclerosis
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Pathological mechanisms in progressive multiple sclerosis.
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Fourth Cooperative Meeting of Consortium of MS Centers and Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis.
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration.
Cognitive impairment in multiple sclerosis.
Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
Title: Pharmacokinetics and Pharmacodynamics of Peginterferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in the Randomised ADVANCE Study.
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.
Daclizumab for relapsing remitting multiple sclerosis.
Rituximab in paediatric onset multiple sclerosis: a case series.
FDA denies Teva Copaxone generic trials petition

Pages